MENU
PTIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protagenic Therapeutics (PTIX) Ownership - Who owns Protagenic Therapeutics?
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders... Show more
Profile
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.62M
P/E Ratio
N/A
Total Cash
1.06M
Projected Growth
N/A
Total Debt
419.76K
Revenue
N/A
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash/Share
0.14
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PTIX
Capitalization
1.62M
P/E Ratio
N/A
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash
1.06M
Total Cash/Share
0.14
Total Debt
420K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
719K
P/B Ratio
1.60
Cash Flow
N/A
Earnings
-1.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
481
Current Ratio
1.80
Current Revenue Per Employee
300634.16
Dividends Per Share - Security
N/A
EBITDA
-5.57M
Float
N/A
Float - Current
N/A
Gross Income Margin
-5.50
Revenue To Assets
-162.74
Shares Held By Institutions
96.4K
Shares Outstanding - Current
7.53M
Total Liabilities
789K
Total Volume MTD
N/A
Value
1
Gain YTD
-56.163
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com